Profound thrombocytopenia with glycoprotein IIb/IIIa inhibitors plus heparin for pump thrombus.
Blais
Danielle M
DM
Sun
Benjamin
B
Vesco
Paul
P
Louis
Louis B
LB
Sai-Sudhakar
Chittoor
C
Firstenberg
Michael S
MS
D009202:Cardiomyopathies / Q000601:surgery*; D000077542:Eptifibatide; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D039661:Integrin beta3 / Q000378:metabolism*; D019934:International Normalized Ratio; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000601:surgery*; D010455:Peptides / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D010976:Platelet Count; D040201:Platelet Membrane Glycoprotein IIb / Q000378:metabolism*; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors*; D013921:Thrombocytopenia / Q000209:etiology*; D013927:Thrombosis / Q000209:etiology*
D039661:Integrin beta3; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D040201:Platelet Membrane Glycoprotein IIb; D010980:Platelet Membrane Glycoproteins; D006493:Heparin; D007770:L-Lactate Dehydrogenase; D000077542:Eptifibatide